Literature DB >> 2406449

Protective immunity induced in mice by detoxified salmonella lipopolysaccharide.

H F Ding1, I Nakoneczna, H S Hsu.   

Abstract

C3H/HeNMTV mice were immunised intraperitoneally (i.p.) with lipopolysaccharide (LPS) or detoxified LPS (D-LPS) derived from Salmonella typhimurium strain SR-11. In both cases, effective protection was achieved against a challenge dose of greater than 2 x 10(2) LD50 of the same organism given by i.p. injection. However, by comparison with LPS, approximately 6- to 10-fold more of D-LPS by weight was needed to protect mice to an equivalent degree. Histopathological studies showed that the initial lesions in infected mice protected with either LPS or D-LPS were composed of self-limiting abscesses which transformed into granulomas as the animals recovered. It is suggested that D-LPS may be modified to become a highly effective, non-toxic salmonella vaccine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406449     DOI: 10.1099/00222615-31-2-95

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  11 in total

1.  Reduction of Tubular Flow Rate as a Mechanism of Oliguria in the Early Phase of Endotoxemia Revealed by Intravital Imaging.

Authors:  Daisuke Nakano; Kent Doi; Hiroaki Kitamura; Takashige Kuwabara; Kiyoshi Mori; Masashi Mukoyama; Akira Nishiyama
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

2.  Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization.

Authors:  T R Licht; K A Krogfelt; P S Cohen; L K Poulsen; J Urbance; S Molin
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

3.  Biphasic, organ-specific, and strain-specific accumulation of platelets induced in mice by a lipopolysaccharide from Escherichia coli and its possible involvement in shock.

Authors:  M Shibazaki; M Nakamura; Y Endo
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

5.  Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.

Authors:  Deborah R Leitner; Sandra Feichter; Kristina Schild-Prüfert; Gerald N Rechberger; Joachim Reidl; Stefan Schild
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

6.  Comparative antibody response to Salmonella antigens in genetically resistant and susceptible mice.

Authors:  H R Xu; Y Y Tan; H S Hsu; C W Moncure; X M Wang
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

7.  The tumor necrosis factor-inducing potency of lipopolysaccharide and uronic acid polymers is increased when they are covalently linked to particles.

Authors:  G Berntzen; T H Flo; A Medvedev; L Kilaas; G Skjåk-Braek; A Sundan; T Espevik
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

8.  Specific Monoclonal Antibody Overcomes the Salmonella enterica Serovar Typhimurium's Adaptive Mechanisms of Intramacrophage Survival and Replication.

Authors:  Swarmistha Devi Aribam; Tomoyuki Harada; Marta Elsheimer-Matulova; Taketoshi Iwata; Katsushi Kanehira; Hirokazu Hikono; Hidenori Matsui; Yohsuke Ogawa; Yoshihiro Shimoji; Masahiro Eguchi
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

9.  Role of polysaccharide and lipid in lipopolysaccharide induced prion protein conversion.

Authors:  Carol L Ladner-Keay; Marcia LeVatte; David S Wishart
Journal:  Prion       Date:  2016-11       Impact factor: 3.931

10.  A universal polysaccharide conjugated vaccine against O111 E. coli.

Authors:  Gabrielle R Andrade; Roger R C New; Osvaldo A Sant'Anna; Neil A Williams; Rosely C B Alves; Daniel C Pimenta; Hugo Vigerelli; Bruna S Melo; Letícia B Rocha; Roxane M F Piazza; Lucia Mendonça-Previato; Marta O Domingos
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.